Interested in seeing how the CPHI community responds to these questions? ✅ Take the survey to share your feedback, and we’ll make sure you get the results just in time before CPHI Milan 2024! 🎁 Plus you will have a chance to win one of the five €100 vouchers. Share your feedback now: https://ow.ly/iNu050SsGcv #CPHIFeedback #survey #AtTheHeartOfPharma #pharma #biopharma
CPHI’s Post
More Relevant Posts
-
MHN is exhibiting at next week's World of Pharmaceutical Market Research conference. Stop by our booth to meet Susan Owens and Andrew Hayes to learn about gaining access to MHN's proprietary panels featuring PATIENTS, PHYSICIANS, and HOSPITAL EXECUTIVES. #mrx #healthcareresearch #qualitativeresearch #MHN #aitransformation #quanitativeresearch #insights #marketingideas #howtoqualitative #PMRC #Quirks
-
-
MHN is exhibiting at next week's World of Pharmaceutical Market Research conference. Stop by our booth to meet Susan Owens and Andrew Hayes and learn about our proprietary panels, featuring PATIENTS, PHYSICIANS and HOSPITAL EXECUTIVES. #mrx #healthcareresearch #qualitativeresearch #MHN #aitransformation #quanitativeresearch #insights #marketingideas #howtoqualitative #PMRC #Quirks
-
-
Our highly anticipated webinar: 'The Battle of Accumulators and Maximizers: What You Need To Know for 2024', will be live on October 26th. 📢 Just Announced 📢 Joining Chris Dowd, ConnectiveRx's SVP of Market Solutions, will be an expert panel that includes Carl Schmid, Kathleen Verb, and Bill Sarraille. This will surely be an informative discussion about the pivotal role and current state of #Copay adjustment programs in the pharmaceutical industry. Register now so you don't miss these value insights 👉 https://lnkd.in/egKTZwnm #CopayAdjustment #PharmaInsights #HealthcareBarriers #PatientAccess
-
-
M&A. Artificial intelligence. The advanced modality pipeline. Peter Rosenorn, Alex Guth and Matthew Mancuso join host Jenny Mackey to discuss these and other trends and challenges shaping the biopharma industry in 2024. Hear more on this episode of Insight Exchange. https://bit.ly/3vQvSQl #biopharma #pharma #medicare #biopharmaceuticals #GenAI #mergersandacquisitions
-
Please plan to participate in this expert webinar on analyzing AAV's with AUC.
Calling all analytical experts! Join Karl Maluf, Ph.D. for an Outsourced Pharma webinar, “How to Identify and Quantify Adeno-associated Virus Fill States Using Analytical Ultracentrifugation,” on Thursday, March 14 at 11:00AM EST. Learn how the analysis of AAV preparations by multiwavelength AUC allows us to identify and quantify different AAV fill states. Learn more and register for the webinar: https://hubs.la/Q02nNNkM0 #KBIBiopharma #AAV #AUC #Biopharma #Analytical
-
-
MHN is exhibiting at next week's World of Pharmaceutical Market Research conference. Stop by our booth to meet Susan Owens and Andrew Hayes to learn about gaining access to MHN's proprietary panels featuring PATIENTS, PHYSICIANS, and HOSPITAL EXECUTIVES. #mrx #healthcareresearch #qualitativeresearch #MHN #aitransformation #quanitativeresearch #insights #marketingideas #howtoqualitative #PMRC #Quirks
-
-
MHN is exhibiting at next week's World of Pharmaceutical Market Research conference. Stop by our booth to meet Susan Owens and Andrew Hayes to learn about gaining access to MHN's proprietary panels featuring PATIENTS, PHYSICIANS, and HOSPITAL EXECUTIVES. #mrx #healthcareresearch #qualitativeresearch #MHN #aitransformation #quanitativeresearch #insights #marketingideas #howtoqualitative #PMRC #Quirks
-
-
LENZ Therapeutics plans to seek FDA approval for its investigational eye drops for #presbyopia, setting up the drug to compete against AbbVie’s #Vuity and Orasis Pharmaceuticals’ #Qlosi. The biopharma recently shared positive Phase 3 data for two formulations of the treatment, saying both met the study’s primary endpoint, though it plans to pursue an #NDA for the version that doesn’t include #brimonidine. In topline data from the CLARITY 1 and 2 trials, LENZ investigated two formulations of #aceclidine: LNZ100 and LNZ101, which contains brimonidine. In the CLARITY 2 trial, LNZ100 won out, with 71% of patients achieving three lines or greater improvement in eyesight after 30 minutes based on the Best Corrected Distance Visual Acuity test. LNZ100 hit the primary endpoint, with 71% of patients achieving three lines or greater improvement in eyesight after 3 hours. About 40% of patients who received that formulation achieved three lines or greater improvement after 10 hours. https://bit.ly/4cISDq9
-
-
M&A. Artificial intelligence. The advanced modality pipeline. Peter Rosenorn, Alex Guth and Matthew Mancuso join host Jenny Mackey to discuss these and other trends and challenges shaping the biopharma industry in 2024. Hear more on this episode of Insight Exchange. https://bit.ly/3vQvSQl #biopharma #pharma #medicare #biopharmaceuticals #GenAI #mergersandacquisitions
-
MHN is exhibiting at next week's World of Pharmaceutical Market Research conference. Stop by our booth to meet Susan Owens and Andrew Hayes to learn about gaining access to MHN's proprietary panels featuring PATIENTS, PHYSICIANS, and HOSPITAL EXECUTIVES. #mrx #healthcareresearch #qualitativeresearch #MHN #aitransformation #quanitativeresearch #insights #marketingideas #howtoqualitative #PMRC #Quirks
-
